Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Sartori

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Cardiologia (Rome, Italy)|April 3, 1999
[Fibrinolysis in ischemic cardiopathy: the role of plasminogen activator inhibitor 1]M Cesari, M T Sartori
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1992
Frequent association of factor VII defects with other clotting disordersA Girolami, M T Sartori, P Zerbinati
Vox Sanguinis|January 1, 1992
Prevalence of bleeding as cause of death in HIV-seropositive patients with congenital clotting disordersM Mares, M T Sartori, A Girolami
Haematologia|January 1, 1991
Portal vein thrombosis in a patient with severe haemophilia A and post-hepatitis liver cirrhosisM T Sartori, M Mares, A Girolami
Thrombosis and Haemostasis|February 3, 1992
The poor reliability of factor X chromogenic assays in coumarin treated patientsA Girolami, M T Sartori, G Boeri
Thrombosis Research|December 1, 1991
The biological inertia of coumarin-induced pre-factors (so called PIVKAs)A Girolami, M T Sartori, P Simioni
British Journal of Haematology|April 1, 1991
An updated classification of factor XIII defectA Girolami, M T Sartori, P Simioni
British Journal of Haematology|September 1, 1989
Different platelet binding sites are probably involved in spontaneous platelet aggregation induced by IIB von Willebrand factor in normals and in IIB von Willebrand's disease patientsA Casonato, M T Sartori, A Girolami
Haematologia|January 1, 1993
Bleeding as a cause of death in HIV-seropositive patients with congenital clotting disordersM Mares, M T Sartori, D Stocco, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 17, 2001
Heterozygous carrier of G20210A prothrombin mutation used oral contraceptive treatment for 23 years without thrombotic events, and developed cerebral venous thrombosis 1 month after resumption of the medication at the age of 50D Tormene, P Simioni, M T Sartori, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Cardiologia (Rome, Italy)|April 3, 1999
[Fibrinolysis in ischemic cardiopathy: the role of plasminogen activator inhibitor 1]M Cesari, M T Sartori
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1992
Frequent association of factor VII defects with other clotting disordersA Girolami, M T Sartori, P Zerbinati
Vox Sanguinis|January 1, 1992
Prevalence of bleeding as cause of death in HIV-seropositive patients with congenital clotting disordersM Mares, M T Sartori, A Girolami
Haematologia|January 1, 1991
Portal vein thrombosis in a patient with severe haemophilia A and post-hepatitis liver cirrhosisM T Sartori, M Mares, A Girolami
Thrombosis and Haemostasis|February 3, 1992
The poor reliability of factor X chromogenic assays in coumarin treated patientsA Girolami, M T Sartori, G Boeri
Thrombosis Research|December 1, 1991
The biological inertia of coumarin-induced pre-factors (so called PIVKAs)A Girolami, M T Sartori, P Simioni
British Journal of Haematology|April 1, 1991
An updated classification of factor XIII defectA Girolami, M T Sartori, P Simioni
British Journal of Haematology|September 1, 1989
Different platelet binding sites are probably involved in spontaneous platelet aggregation induced by IIB von Willebrand factor in normals and in IIB von Willebrand's disease patientsA Casonato, M T Sartori, A Girolami
Haematologia|January 1, 1993
Bleeding as a cause of death in HIV-seropositive patients with congenital clotting disordersM Mares, M T Sartori, D Stocco, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 17, 2001
Heterozygous carrier of G20210A prothrombin mutation used oral contraceptive treatment for 23 years without thrombotic events, and developed cerebral venous thrombosis 1 month after resumption of the medication at the age of 50D Tormene, P Simioni, M T Sartori, et al.
Pageof 7